Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 5 of 7
-
March 22, 2018
Grant bolsters study of potential new therapy for C. diff infection
According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis. -
March 1, 2018
Study reveals safety signal from genes that mimic drugs
Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center. -
February 8, 2018
Event showcases REDCap’s data management versatility
Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe. -
September 21, 2017
New lab formulary improves quality, cuts cost
An effort at Vanderbilt University Medical Center (VUMC) to enhance clinical decision making through cross-departmental collaboration and effective use of diagnostics has improved patient care and saved the institution more than $1 million in 2016, VUMC officials reported this week. -
September 21, 2017
Translational Research Forum set for Oct. 13
Jacob Corn, Ph.D., a pioneer in next-generation genome editing at the University of California Berkeley, will be the guest speaker at the 2017 Vanderbilt Translational Research Forum Oct. 13 at the Student Life Center. -
September 7, 2017
Community key to gender identity research effort
One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement. -
August 7, 2017
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.